Patents by Inventor Gunnar Bjursell

Gunnar Bjursell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120053114
    Abstract: The invention provides methods of screening test compounds for their ability to reduce retention of atherogenic lipoproteins in atherogenesis by measuring their activity as a modulator of the binding affinity of CEL (Carboxyl Ester Lipase) to various receptors. The invention further provides methods for the use of active modulators of the binding affinity of CEL to receptors for the prevention and treatment of atherosclerosis.
    Type: Application
    Filed: November 8, 2011
    Publication date: March 1, 2012
    Inventors: Karl Gunnar Bjursell, Jeanette Annika Nilsson, Sara Ellmark
  • Publication number: 20080262108
    Abstract: The invention provides methods of screening test compounds for their ability to reduce retention of atherogenic lipoproteins in atherogenesis by measuring their activity as a modulator of the binding affinity of CEL (Carboxyl Ester Lipase) to various receptors. The invention further provides methods for the use of active modulators of the binding affinity of CEL to receptors for the prevention and treatment of atherosclerosis.
    Type: Application
    Filed: April 1, 2005
    Publication date: October 23, 2008
    Inventors: Karl Gunnar Bjursell, Jeanette Annika Nilsson, Sara Ellmark
  • Patent number: 4331662
    Abstract: Compositions for inhibiting cell growth, particularly compositions for the reatment of virus infections, are provided comprising the nucleoside 2'-azido-2'-desoxycytidine.
    Type: Grant
    Filed: February 4, 1980
    Date of Patent: May 25, 1982
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Fritz Eckstein, John B. Hobbs, Lambert Skoog, Gunnar Bjursell, Lars Thelander